S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
NYSE:EBS

Emergent BioSolutions Insider Trades

$41.89
-0.83 (-1.94%)
(As of 12/3/2021 12:00 AM ET)
Add
Compare
Today's Range
$41.61
$43.76
50-Day Range
$33.11
$55.01
52-Week Range
$29.88
$127.20
Volume
806,821 shs
Average Volume
1.75 million shs
Market Capitalization
$2.25 billion
P/E Ratio
9.97
Dividend Yield
N/A
Beta
0.95

Emergent BioSolutions (NYSE:EBS) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
10.40%

Number Of
Insiders Buying
(Last 12 Months)
1

Amount Of
Insider Buying
(Last 12 Months)
$112.38 K

Number Of
Insiders Selling
(Last 12 Months)
3

Amount Of
Insider Selling
(Last 12 Months)
$5.36 M

Skip Chart & View Insider Trade History

Insider Buying and Selling by Quarter

Get EBS Insider Trade Alerts

Want to know when executives and insiders are buying or selling Emergent BioSolutions stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.


Emergent BioSolutions (NYSE EBS) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/15/2021Richard S LindahlCFOBuy3,000$37.46$112,380.00  
5/25/2021Kathryn C ZoonDirectorSell3,139$56.48$177,290.7214,377  
3/4/2021Sue BaileyDirectorSell8,168$92.37$754,478.1624,427  
1/21/2021Robert KramerCEOSell21,900$110.03$2,409,657.00141,442  
1/15/2021Robert KramerCEOSell19,026$106.01$2,016,946.26  
11/2/2020Fuad El-HibriChairmanSell20,000$90.44$1,808,800.001,143,988  
9/24/2020Fuad El-HibriMajor ShareholderSell25,535$99.73$2,546,605.551,136,523  
9/16/2020Fuad El-HibriChairmanSell20,000$102.48$2,049,600.001,169,523  
9/10/2020Fuad El-HibriMajor ShareholderSell40,000$102.73$4,109,200.001,209,523  
9/2/2020Louis W SullivanDirectorSell28,418$111.22$3,160,649.9642,762  
8/17/2020Zsolt HarsanyiDirectorSell6,609$133.71$883,689.3924,579  
8/11/2020George A JoulwanDirectorSell6,000$124.11$744,660.0026,771  
6/3/2020Ronald RichardDirectorSell6,572$87.51$575,115.724,269  
5/11/2020Zsolt HarsanyiDirectorSell4,940$81.99$405,030.6024,933  
5/5/2020Ronald RichardDirectorSell8,375$80.19$671,591.258,020  
4/29/2020Fuad El-HibriChairmanSell20,000$74.24$1,484,800.001,249,523  
4/27/2020Ronald RichardDirectorSell7,893$78.00$615,654.0024,288  
4/22/2020Fuad El-HibriChairmanSell20,000$66.81$1,336,200.001,289,523  
4/20/2020Adam HaveyEVPSell17,009$69.00$1,173,621.0054,670  
4/17/2020Adam HaveyEVPSell20,414$65.00$1,326,910.0054,670  
4/15/2020Fuad El-HibriChairmanSell12,537$62.58$784,565.461,348,321  
4/13/2020Fuad El-HibriChairmanSell17,071$62.25$1,062,669.751,348,321  
4/8/2020Fuad El-HibriChairmanSell37,362$61.13$2,283,939.061,413,470  
4/6/2020Adam HaveyEVPSell7,972$60.00$478,320.0037,986  
4/6/2020Fuad El-HibriChairmanSell28,240$60.50$1,708,520.001,440,806  
3/16/2020Zsolt HarsanyiDirectorSell6,400$65.00$416,000.0029,873  
3/4/2020Kathryn C ZoonDirectorSell991$60.65$60,104.1516,421  
2/26/2020Fuad El-HibriChairmanSell13,619$58.70$799,435.301,482,663  
2/20/2020Fuad El-HibriChairmanSell4,751$64.90$308,339.901,483,769  
2/18/2020Fuad El-HibriChairmanSell15,614$63.90$997,734.601,483,404  
2/14/2020Fuad El-HibriChairmanSell4,386$63.90$280,265.401,483,404  
2/12/2020Fuad El-HibriChairmanSell13,720$62.90$862,988.001,485,298  
2/5/2020Fuad El-HibriChairmanSell48,316$60.66$2,930,848.561,430,702  
1/16/2020Zsolt HarsanyiDirectorSell3,435$55.00$188,925.0036,273  
12/12/2019Sue BaileyDirectorSell8,375$53.46$447,727.5046,333  
11/18/2019Kathryn C ZoonDirectorSell1,000$54.06$54,060.00
11/8/2019Kathryn C ZoonDirectorSell3,082$54.15$166,890.3018,412  
9/9/2019Kathryn C ZoonDirectorSell1,509$56.12$84,685.0821,494  
5/28/2019Kathryn C ZoonDirectorSell1,376$43.39$59,704.6424,379  
3/11/2019Adam HaveyEVPSell2,430$56.93$138,339.9032,240  
3/4/2019Daniel Abdun-NabiCEOSell14,565$58.11$846,372.15142,617  
3/1/2019Adam HaveyEVPSell3,043$58.11$176,828.7336,694  
2/28/2019Fuad El-HibriChairmanSell27,725$58.83$1,631,061.751,478,306  
2/26/2019Fuad El-HibriChairmanSell10,369$59.65$618,510.851,478,306  
11/27/2018Fuad El-HibriChairmanSell45,832$69.79$3,198,615.281,428,502  
11/27/2018Sue BaileyDirectorSell17,717$69.62$1,233,457.5457,216  
11/20/2018Fuad El-HibriChairmanSell35,173$69.75$2,453,316.75  
11/7/2018Kathryn C ZoonDirectorSell4,242$69.74$295,837.0833,972  
11/2/2018Adam HaveyEVPSell8,179$64.25$525,500.7531,264  
10/16/2018Adam HaveyEVPSell22,996$61.06$1,404,135.7636,079  
9/17/2018Daniel Abdun-NabiCEOSell1,319$65.00$85,735.00194,787  
9/14/2018Daniel Abdun-NabiCEOSell28,220$65.00$1,834,300.00194,787  
9/5/2018Daniel Abdun-NabiCEOSell90,776$60.18$5,462,899.68257,343  
8/21/2018Ronald RichardDirectorSell7,893$60.02$473,737.8621,063  
8/14/2018Fuad El-HibriChairmanSell36,318$55.98$2,033,081.64  
8/3/2018Ronald RichardDirectorSell100$60.00$6,000.0021,063  
7/12/2018Fuad El-HibriChairmanSell15,000$54.50$817,500.001,527,593  
7/9/2018Fuad El-HibriChairmanSell15,000$53.61$804,150.001,539,993  
6/11/2018George A JoulwanDirectorSell5,000$52.89$264,450.0030,272  
6/6/2018Kathryn C ZoonDirectorSell376$52.81$19,856.5622,885  
6/5/2018Daniel Abdun-NabiCEOSell15,785$52.11$822,556.35197,343  
5/24/2018Kathryn C ZoonDirectorSell1,377$51.15$70,433.55  
4/17/2018Ronald RichardDirectorSell7,893$55.00$434,115.0031,303  
3/12/2018Adam HaveyEVPSell5,842$52.82$308,574.4435,756  
3/1/2018Adam HaveyEVPSell1,898$49.50$93,951.00  
1/22/2018Jerome M HauerDirectorSell5,152$50.91$262,288.3223,797  
1/2/2018Daniel Abdun-NabiCEOSell21,906$47.91$1,049,516.46226,040  
12/13/2017Daniel Abdun-NabiCEOSell20,000$45.99$919,800.00224,134  
12/12/2017Ronald RichardDirectorSell23,681$45.02$1,066,118.6247,091  
12/7/2017Zsolt HarsanyiDirectorSell7,000$42.47$297,290.0037,077  
11/29/2017Fuad El-HibriChairmanSell47,983$41.88$2,009,528.041,550,216  
11/14/2017Fuad El-HibriChairmanSell40,000$40.37$1,614,800.00  
11/7/2017George A JoulwanDirectorSell14,251$41.24$587,711.2434,323  
11/3/2017Daniel Abdun-NabiCEOSell31,508$42.77$1,347,597.16215,642  
9/29/2017Fuad El-HibriChairmanSell25,000$40.50$1,012,500.001,555,216  
9/28/2017Ronald RichardDirectorSell22,415$40.00$896,600.0024,676  
9/27/2017Adam HaveyEVPSell7,885$39.50$311,457.5033,931  
9/27/2017Daniel Abdun-NabiCEOSell15,000$39.92$598,800.00219,134  
9/27/2017Fuad El-HibriChairmanSell25,000$39.50$987,500.001,555,216  
9/27/2017Ronald RichardDirectorSell1,266$40.00$50,640.0024,676  
9/14/2017Fuad El-HibriChairmanSell25,000$38.50$962,500.001,603,763  
9/8/2017Adam HaveyEVPSell7,885$37.06$292,218.1033,931  
9/7/2017Fuad El-HibriChairmanSell16,439$37.50$616,462.501,605,216  
9/5/2017Fuad El-HibriChairmanSell3,100$37.50$116,250.001,621,655  
8/31/2017Daniel Abdun-NabiCEOSell15,000$37.21$558,150.00219,134  
8/31/2017Fuad El-HibriChairmanSell5,461$37.50$204,787.501,624,755  
8/15/2017Jerome M HauerDirectorSell10,776$35.83$386,104.0829,421  
7/27/2017Fuad El-HibriChairmanSell25,000$36.50$912,500.001,630,216  
7/20/2017Fuad El-HibriChairmanSell25,000$35.50$887,500.001,655,216  
4/3/2017Adam HaveyEVPSell11,419$28.62$326,811.7826,046  
3/8/2017Jerome M HauerDirectorSell2,576$31.27$80,551.5217,404  
1/17/2017Adam HaveyEVPSell8,438$29.75$251,030.5041,424  
1/17/2017Sue BaileyDirectorSell19,424$29.78$578,446.7234,637  
1/10/2017Daniel Abdun-NabiInsiderSell28,240$31.28$883,347.20172,945  
12/13/2016Ronald RichardDirectorSell5,900$34.09$201,131.0019,870  
6/6/2016George A JoulwanDirectorSell4,700$44.12$207,364.0020,785  
6/1/2016Daniel Abdun-NabiCEOSell8,699$43.74$380,494.26170,966  
5/27/2016Fuad El-HibriMajor ShareholderSell9,835$43.50$427,822.501,649,073  
5/26/2016Fuad El-HibriMajor ShareholderSell39,759$43.13$1,714,805.671,698,667  
5/25/2016Fuad El-HibriMajor ShareholderSell85,000$42.52$3,614,200.001,719,073  
5/25/2016Zsolt HarsanyiDirectorSell27,867$42.33$1,179,610.1141,685  
5/24/2016Fuad El-HibriChairmanSell20,000$42.26$845,200.001,719,073  
5/23/2016Fuad El-HibriChairmanSell45,000$42.62$1,917,900.001,719,073  
5/20/2016Daniel Abdun-NabiCEOSell8,701$42.00$365,442.00179,665  
5/19/2016Jerome M HauerDirectorSell3,134$41.22$129,183.4820,085  
5/13/2016Louis W SullivanDirectorSell47,631$39.21$1,867,611.5128,800  
5/12/2016Fuad El-HibriMajor ShareholderSell25,000$38.71$967,750.001,699,073  
5/12/2016Jerome M HauerDirectorSell4,700$38.50$180,950.0018,800  
5/11/2016Louis W SullivanDirectorSell9,969$39.25$391,283.2538,469  
4/22/2016Fuad El-HibriMajor ShareholderSell4,209$40.50$170,464.501,724,073  
4/18/2016Daniel Abdun-NabiCEOSell8,702$40.17$349,559.34194,319  
4/18/2016Fuad El-HibriMajor ShareholderSell20,791$40.50$842,035.501,728,282  
4/6/2016Fuad El-HibriMajor ShareholderSell50,000$39.00$1,950,000.001,774,073  
4/6/2016Robert KramerEVPSell21,786$38.90$847,475.4077,551  
4/4/2016Robert KramerEVPSell21,788$36.90$803,977.2080,597  
4/1/2016Robert KramerEVPSell43,572$35.56$1,549,420.3291,607  
3/14/2016Adam HaveyEVPSell4,359$33.96$148,031.6439,163  
3/14/2016Jerome M HauerDirectorSell2,350$33.88$79,618.0014,100  
3/11/2016Adam HaveyEVPSell11,112$33.84$376,030.0854,254  
3/11/2016Louis W SullivanDirectorSell14,879$34.03$506,332.3743,379  
3/7/2016Marvin L WhiteDirectorSell33,134$35.42$1,173,606.2841,100  
1/4/2016Sue BaileyDirectorSell11,520$38.79$446,860.8028,500  
12/30/2015Ronald RichardDirectorSell21,600$40.00$864,000.0013,733  
12/24/2015Daniel Abdun-NabiCEOSell63,209$39.06$2,468,943.54185,368  
11/19/2015Fuad El-Hibrimajor shareholderSell17,871$37.50$670,162.501,852,284  
11/13/2015Fuad El-Hibrimajor shareholderSell13,013$36.50$474,974.501,842,255  
11/12/2015Barry LabingerEVPSell36,126$35.64$1,287,530.6428,558  
11/9/2015Fuad El-Hibrimajor shareholderSell13,225$35.50$469,487.501,835,268  
11/6/2015Fuad El-Hibrimajor shareholderSell13,450$34.50$464,025.001,828,493  
11/3/2015Fuad El-Hibrimajor shareholderSell13,689$33.50$458,581.501,821,943  
9/11/2015Sue BaileyDirectorSell6,080$32.37$196,809.6028,500  
8/13/2015George A JoulwanDirectorSell7,200$34.72$249,984.00  
7/20/2015Fuad El-HibriChairmanSell234$34.50$8,073.00  
7/13/2015Ronald RichardDirectorSell4,922$34.00$167,348.00  
6/29/2015Ronald RichardDirectorSell4,923$32.76$161,277.48  
6/22/2015Fuad El-HibriMajor ShareholderSell74,564$32.60$2,430,786.40  
6/16/2015Louis W SullivanDirectorSell13,457$31.33$421,607.81  
6/15/2015Adam HaveyEVPSell36,298$31.55$1,145,201.90  
6/15/2015Fuad El-HibriMajor ShareholderSell45,436$32.18$1,462,130.48  
1/20/2015Fuad El-HibriMajor ShareholderSell15,325$27.67$424,042.75  
12/26/2014Ronald RichardDirectorSell5,000$28.00$140,000.00  
12/17/2014Ronald RichardDirectorSell5,000$27.00$135,000.00  
12/11/2014Fuad El-HibriMajor ShareholderSell119,341$26.00$3,102,866.00  
11/28/2014Fuad El-HibriMajor ShareholderSell34,577$25.00$864,425.00  
11/25/2014Fuad El-HibriMajor ShareholderSell9,014$25.00$225,350.00  
11/25/2014Zsolt HarsanyiDirectorSell8,000$24.82$198,560.00  
11/12/2014Fuad El-HibriMajor ShareholderSell2,311$25.00$57,775.00  
11/7/2014Robert KramerCFOSell2,625$24.00$63,000.00  
4/16/2014Robert KramerCFOSell50,189$24.34$1,221,600.2662,183  
3/12/2014Adam HaveyEVPSell11,562$27.50$317,955.0036,145  
3/11/2014Adam HaveyEVPSell17,655$26.96$475,978.8036,920  
(Data available from 1/1/2013 forward)












Emergent BioSolutions (NYSE:EBS) Insider Trade Frequently Asked Questions

Who is on Emergent BioSolutions's Insider Roster?

The list of insiders at Emergent BioSolutions includes Adam Havey, Daniel Abdun-Nabi, Fuad El-Hibri, George A Joulwan, Kathryn C Zoon, Louis W Sullivan, Richard S Lindahl, Robert Kramer, Ronald Richard, Sue Bailey, and Zsolt Harsanyi.Learn more on EBS's insiders

What percentage of Emergent BioSolutions stock is owned by insiders?

10.40% of Emergent BioSolutions stock is owned by insiders. Learn more on EBS's insider holdings

Which Emergent BioSolutions insiders have been buying company stock?

The following insider purchased Emergent BioSolutions stock in the last 24 months: Richard S Lindahl ($112,380.00).

How much insider buying is happening at Emergent BioSolutions?

Insiders have purchased a total of 3,000 Emergent BioSolutions shares in the last 24 months for a total of $112,380.00 bought.

Which Emergent BioSolutions insiders have been selling company stock?

The following insiders have sold Emergent BioSolutions stock in the last 24 months: Adam Havey ($2,978,851.00), Fuad El-Hibri ($25,354,511.58), George A Joulwan ($744,660.00), Kathryn C Zoon ($237,394.87), Louis W Sullivan ($3,160,649.96), Robert Kramer ($4,426,603.26), Ronald Richard ($1,862,360.97), Sue Bailey ($1,202,205.66), and Zsolt Harsanyi ($1,893,644.99).

How much insider selling is happening at Emergent BioSolutions?

Insiders have sold a total of 526,787 Emergent BioSolutions shares in the last 24 months for a total of $41,860,882.29 sold.

This page was last updated on 12/4/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.